WEBULL
WebtradeDownload

Roche Bobois (ENXTPA:RBO) Stock Faces Margin Squeeze And Rich Valuation

Simply Wall St · 1d ago

Roche Bobois stock has been under pressure, with the share price down about 20% over the past three months and roughly 8% over the past month. The latest half year report did not change that mood. H1 2026 revenue came in at €187.8 million and net income at €3.3 million, keeping the trailing net profit margin around 2%, below last year’s 3.2% level.

The short term story is a luxury furniture group experiencing thinner profitability. The longer term question is whether a business priced on a P/E of 26.6x, with a rich DCF value, can rebuild those margins.

Is Roche Bobois a genuinely mispriced cash flow story, or just an expensive low margin retailer in disguise? See how the current share price compares with our valuation analysis for Roche Bobois

H1 2026 Earnings Summary

  • Revenue (H1 2026 vs H1 2025): €187.8 million vs €206.232 million (down about 9%)
  • Net Income (H1 2026 vs H1 2025): €3.3 million vs €5.77 million (down about 43%)
  • Basic EPS (H1 2026 vs H1 2025): Not disclosed for H1 2026 vs €0.569352 in H1 2025 (directionally weaker given lower profit)
  • Net Profit Margin (Trailing 12 Months vs Prior Year): Around 2% vs 3.2% a year earlier (compressed profitability)

Prefer clean visuals instead of another wall of earnings tables and margin figures? View Roche Bobois' full financial picture, including a detailed valuation breakdown and charts on profitability and cash generation, in the company report for Roche Bobois.

ENXTPA:RBO Trailing 12-Month Revenue & Expenses Breakdown as at Sep 2026
ENXTPA:RBO Trailing 12-Month Revenue & Expenses Breakdown as at Sep 2026

Roche Bobois bulls face a tougher earnings reality

For anyone leaning bullish on Roche Bobois as a premium brand story, these numbers ask for patience. Revenue in H1 2026 is lower than a year ago and net income has fallen faster, which keeps the trailing net margin close to 2%. That is thin for an aspirational design label that many investors hope can convert brand equity into healthy cash. The wider share price decline over 3 and 12 months suggests the market is already questioning how quickly this business can rebuild profitability.

Profit squeeze keeps the Roche Bobois bear case alive

The more cautious view finds support in this set of results. Earnings dropped sharply year on year while the trailing net margin slipped from 3.2% to about 2%. That pattern fits a discretionary retailer facing softer demand and less pricing power. Recent share price performance, with the stock down over 20% in three months, also lines up with concerns that this is a low margin model under pressure rather than a straightforward cash machine. Bears will argue the burden of proof now sits firmly on future margin repair.

Compare how that thinner 2% trailing net margin and the recent €19.95 share price stack up against institutional expectations. See the consensus price target analysis for Roche Bobois to gauge whether analysts think Roche Bobois can earn back the premium multiple investors are paying today.

Take Charge Of Your Next Move

Roche Bobois has seen its share price and margins come under pressure recently, which makes timing and entry price even more important for anyone considering the stock. Register for free with Simply Wall St and add Roche Bobois to your Watchlist to track price against fair value and watch how profitability trends evolve before deciding when to act. After you own it, use the Portfolio Command Center to cut through noise and focus on the key events that matter to your holdings. Stay plugged into wider sentiment and thesis checks by tapping into thousands of investor viewpoints through the Community to help you spot hidden catalysts and risks early and keep a step ahead of the market.

Seeking Alternatives Beyond Roche Bobois?

Fresh ideas move first. Breakout stories, momentum shifts and quietly dropping valuations often get caught early, then fly once the crowd arrives. Scan these under the radar picks and act now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.